As of 2024-12-11, the Fair Value of KemPharm Inc (KMPH) is -3.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.81 USD, the upside of KemPharm Inc is -159.56%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -8.56 | -41.54 | - | - | -25.05 | |
| YoY growth | 32.95% | -385.60% | - | - | -176.32% | |
| Market Cap (mil) | 200.47 |
| P/E | |
| Forward P/E |
| EPS | -0.69 |
| Avg earnings growth rate | -176.32% |
| TTM earnings | -41.54 |